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Renal angiomyolipoma is a benign tumour of the
kidney that can lead to long term morbidity irre-
spective of renal function.
Case report
A giant renal angiomyolipoma (AML) measuring
18 × 13.2 × 22.4 cm was found in the left kidney
of this 43-year-old female (with no evidence of
tuberous sclerosis [TS]). Her other kidney was
atrophic contributing only 3% of total renal func-
tion (damaged by chronic pelvi-ureteric junction
obstruction). The grossly hypertrophied left
kidney was causing displacement of the ureter,
pancreas and spleen (Figure 1). There was gross
neovascularization within the AML, and the
patient suffered three life threatening episodes of
haemorrhage requiring interventional radiologi-
cal procedures which attempted to coil the arterio-
venous malformations. On one of these occasions
the procedure caused a renal artery aneurysm and
a radiological attempt at repair resulted in contrast
induced anaphylaxis thereby precluding any
further radiological attempts. Owing to the risk
of further haemorrhagic episodes, a difﬁcult
decision was made to attempt a partial nephrect-
omy to excise the angiomyolipoma – at this risk
of rendering the patient effectively anephric and
dialysis dependent if total nephrectomy had to
be performed to control bleeding.
Intraoperatively the surgeons were able to suc-
cessfully resect a segment of AML measuring 14 ×
19 cm. Postoperatively there was a prolonged
period of hypotension requiring inotropic
support and blood product replacement. She
underwent three further abdominal operations to
investigate and treat ongoing blood loss and
abdominal compartment syndrome. This was
subsequently exacerbated by intra-abdominal
sepis – perihepatic collections necessitating ultra-
sound guided drainage and episodes of pneumo-
niae with multiple courses of intravenous
antibiotics. During her ITU course she required
haemoﬁltration, ventilation via a tracheostomy
and total parenteral nutrition. Upon clinical
improvement a right sided homonymous hemia-
nopia was noted, with evidence of a left posterior
circulation artery territory ischaemia demon-
strated on head MRI scan (Figure 2). The patient
made a very slow recovery and was discharged
50 days later, with normal renal function, a large
open abdominal wound (left to heal by secondary
intention) and a new visual ﬁeld defect. She has
subsequently developed an incisional hernia and
the visual defect has failed to resolve.
Discussion
AML was ﬁrst described by Bourneville (1880),
and is considered a benign hamartoma with poly-
clonal proliferation. AML can befound in multiple
forms; classic, microscopic, cystic, epithelioid,
oncocytoma-like.
1 They are more common than
previously thought and it is now estimated that
they affect 13 per 10000 adults.
2 Recently, clonal
neoplasm and AML have been reclassiﬁed
within a family of peri-vascular epithelioid cell
tumours (PEComas).
1
The most frequent form orclassic AML; is com-
posed of adipose tissue, spindle cells, epithelioid
smooth muscle cells and abnormally thick
walled blood vessels.
1 There is an association (esti-
mated 10%) with TS, where the AMLs are more
likely – and are frequently bilateral, small and
multifocal.
2 However, cases of massive AMLs
(measuring up to 45 × 20 × 15 cm) have also
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1been reported.
3 Sporadic AMLs have a female pre-
ponderance, occurring between the ages of 30 and
50 years, and are more often unilateral and larger
in size.
1
DiagnosticallyAMLsareachallengeasradiologi-
cal appearances vary, making it difﬁcult to differen-
tiate from a renal cell carcinoma (RCC). Current
modalities of radiological analysis are ultrasound
(US),computedtomography(CT)andmagneticres-
onanceimaging(MRI).OnUS,AMLissuggestedby
a strongly hyper-reﬂective lesion with acoustic sha-
dowing, however they can also be hypo- or iso-
reﬂective. Siegel et al.
4 demonstrated an overlap in
US appearances; such that up to 12% RCCs were
sonographically indistinguishable from AML.
Uncertainty on US usually leads to investigation
with CT, where the classical appearance is a fat con-
taining homogenous mass. MRI scanning reveals
high signal intensity from fat on T1-weighted
images. Using these techniques, 100% of AMLs
were correctly identiﬁed in one study.
5
Lesions less than 4cm are generally managed
conservatively, however larger AMLs (>4 cm)
are symptomatic in approximately 90% of cases
and necessitate intervention.
5 Common problems
are abdominal pain, palpable mass causing com-
pressive symptoms and spontaneous aneurysm
rupture.
5 Oesterling et al. (1986) proposed that
patients with symptomatic AML greater than 4
cm should undergo angiogram and transcatheter
renal artery embolization, enucleation or partial
nephrectomy.
5 In practise this remains difﬁcult
to implement as evidenced by a case described
by Galanis et al.
6 who reported a very large unilat-
eral AML (31 × 16.5 × 8.5 cm) for which acomplete
nephrectomy was performed.
6 More recent evi-
dence suggests that aneurysm size is more impor-
tant than tumour size in determining risk of
bleeding. A total of 14.3% of patients with
lesions studied by Yamakado et al., with minimal
vascularity (few small stretched vessels), pre-
sented with haemorrhage versus 50% of those
displaying marked vascularity (multiple, large
tortuous vessels).
7
Novel treatment options investigate the role of
vascular endothelial growth factor (VEGF) inhi-
bition. AML cells produce VEGF in vitro which
subsequently drives angiogenesis thereby further
increasing vascularity within the AML. Anti-
angiogenic drugs such as cyclooxygenase-2
inhibitors, interferons, thalidomide, retinoids
have been poorly studied in benign tumours –
however Arbiser et al. (2002) hypothesize that
these agents may impede growth as they do in
malignant tumours.
8 Bissler et al. (2008) demon-
strated twelve months of treatment with sirolimus
caused a reduction in AML volume to 27% of
baseline – upon discontinuation of treatment
there was subsequent increase in size; multicentred
placebo controlled trials are currently underway to
explore this further.
9 We have not considered this
option in this patient who has residual AML
because of possible side effects (sirolimus is associ-
atedwith impairedwound healing and excess rates
of hernia formation
10) in a lady whose clinical
course to date has been very challenging.
Summary
A case of allegedly benign giant renal AML is pre-
sented here because of its uncommon occurrence
in an effectively single kidney and the huge clini-
cal dilemma it presented for her clinicians, as well
as the poor overall outcome for the patient despite
eventual satisfactory renal outcome.
Figure 1
Magnetic resonance angiogram: Massive left sided AML with
displacement of spleen and ureter
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Figure 2
Axial T2 weighted MRI image: High signal intensity in left occipital
lobe demonstrating acute ischaemic stroke
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